Back

LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - Rebuttal PRO

26 August 2018 (17:09 - 17:21)
Organised by:
Congress Presentation Part of: LAA occlusion - The next big thing? Atrial Fibrillation (AF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - PRO
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - CON
Doctor J. Mandrola (Louisville, US)
Slides Video
Presentation thumbnail
LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - Rebuttal CON
Doctor J. Mandrola (Louisville, US)
Slides Video
Presentation thumbnail
Panel Discussion
Video

Access the full session

Session thumbnail
LAA occlusion - The next big thing?

The Event

Event poster

ESC Congress 2018

26 August 2018 17:09 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage closure in atrial fibrillation: gaps in knowledge
1 September 2025
thumbnail
Congress Presentation
Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
26 August 2022
thumbnail
Congress Session
Management of atrial fibrillation: knowns and unknowns
31 August 2024
thumbnail
Congress Presentation
Left atrial appendage closure in patients with cancer
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources